Dr. Möhrke, Werner
Medical Department, Procter and Gamble Pharmaceuticals
Publications
- Effect of switching branded risedronate to branded or generic alendronate on medication compliance with weekly bisphosphonates: a cohort study utilizing the dapi prescription claims database
- Switching from branded alendronate or risedronate to generic alendronate: effect on persistence with bisphosphonate therapy in Germany
- Switching from branded alendronate or risedronate to generic alendronate: effect on persistence with bisphosphonate therapy in Germany (1)
- Beeinflusst die Umstellung von Risedronat oder Alendronat Originalprodukten auf Generika die Compliance (Persistenz)?